This inventor holds 1 USPTO granted patent. Top assignee: Regeneron Pharmaceuticals, Inc.. Active years: 2003.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2003
Title: Inventor Profile: Kurt Stockli-Rippstein
Introduction
Kurt Stockli-Rippstein is an accomplished inventor based in Munich, Germany. He has made significant contributions to the field of biotechnology, holding a notable patent that impacts the understanding and production of proteins essential for human health.
Latest Patents
Kurt holds one patent titled "DNA encoding human ciliary neurotrophic factor and method for producing the protein encoded thereby." This patent focuses on advancing the methods of generating this important protein, which plays a crucial role in various biological processes.
Career Highlights
Currently, Kurt is employed at Regeneron Pharmaceuticals, Inc., a leading biotechnology company that pioneers the development of innovative medicines. His work there reflects his commitment to advancing medical science and improving patient outcomes through groundbreaking research and inventions.
Collaborations
Throughout his career, Kurt has collaborated with esteemed colleagues, including Michael Sendtner and Friedrich Lottspeich. These partnerships highlight the collaborative nature of research in the life sciences and underscore the importance of teamwork in driving innovation.
Conclusion
Kurt Stockli-Rippstein exemplifies the spirit of innovation in the biotechnology sector. His patent and ongoing work at Regeneron Pharmaceuticals, Inc. contribute to the advancement of scientific knowledge and the development of new therapeutic options for patients, marking him as an influential figure in his field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile